Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ESGO statement on cervical cancer vaccination.
Vergote I, van der Zee AG, Kesic V, Sert B, Robova H, Rob L, Reed N, Luesley DM, Leblanc E, Hagen B, Gitsch G, du Bois A, di Vagno G, Colombo N, Beller U, Ayhan A, Jacobs I. Vergote I, et al. Among authors: leblanc e. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1183-5. doi: 10.1111/j.1525-1438.2007.01129.x. Int J Gynecol Cancer. 2007. PMID: 17997794 No abstract available.
Outcomes of pre-operative brachytherapy followed by hysterectomy for early cervical cancer.
Bataille B, Escande A, Le Tinier F, Parent A, Bogart E, Collinet P, Bresson L, Narducci F, Leblanc E, Lemaire AS, Taieb S, Lartigau E, Mirabel X, Cordoba A. Bataille B, et al. Among authors: leblanc e. Int J Gynecol Cancer. 2020 Feb;30(2):181-186. doi: 10.1136/ijgc-2019-000617. Epub 2019 Dec 22. Int J Gynecol Cancer. 2020. PMID: 31871113
Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
Angeles MA, Baissas P, Leblanc E, Lusque A, Ferron G, Ducassou A, Martínez-Gómez C, Querleu D, Martinez A. Angeles MA, et al. Among authors: leblanc e. Int J Gynecol Cancer. 2019 Mar;29(3):480-486. doi: 10.1136/ijgc-2018-000168. Epub 2019 Feb 1. Int J Gynecol Cancer. 2019. PMID: 30712019
Oncological outcome of surgical management in patients with recurrent uterine cancer-a multicenter retrospective cohort study-CEEGOG EX01 Trial.
Germanova A, Raspagliesi F, Chiva L, Dusek L, Arvas M, Leblanc E, Lengeyl T, Di Donato V, Zaal A, Dursun P, Zapardiel I, Turan T, Triginelli SA, Kim SW, Jurado M, Sehouli J, Sehnal B, Masak L, loanid N, Dreyer G, Jach R, Mlynček M, Chiappa V, Martinelli F, Slama J, Kocian R, Bogani G, Cibula D. Germanova A, et al. Among authors: leblanc e. Int J Gynecol Cancer. 2019 May;29(4):711-720. doi: 10.1136/ijgc-2019-000292. Int J Gynecol Cancer. 2019. PMID: 31064862
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B, Chereau E, Bergzoll C, Querleu D. Luyckx M, et al. Among authors: leblanc e. Int J Gynecol Cancer. 2012 Oct;22(8):1337-43. doi: 10.1097/IGC.0b013e31826a3559. Int J Gynecol Cancer. 2012. PMID: 22964527
559 results